• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性胃癌的历史、发病机制和治疗:约翰二十三世家族的原始研究。

History, pathogenesis, and management of familial gastric cancer: original study of John XXIII's family.

机构信息

Department of Human Pathology and Oncology, Section of General Surgery and Surgical Oncology and Translational Research Laboratory, University of Siena, Viale Bracci, 53100 Siena, Italy.

出版信息

Biomed Res Int. 2013;2013:385132. doi: 10.1155/2013/385132. Epub 2012 Dec 26.

DOI:10.1155/2013/385132
PMID:23484115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3591243/
Abstract

BACKGROUND

Hereditary diffuse gastric cancer is associated with the E-cadherin germline mutations, but genetic determinants have not been identified for familial intestinal gastric carcinoma. The guidelines for hereditary diffuse gastric cancer are clearly established; however, there are no defined recommendations for the management of familial intestinal gastric carcinoma.

METHODS

In this study we describe Pope John XXIII's pedigree that harboured gastric cancer as well as six other family members. Family history was analysed according to the International Gastric Cancer Linkage Consortium criteria, and gastric tumours were classified in accord with the last Japanese guidelines.

RESULTS

Seven out of 109 members in this pedigree harboured gastric cancer, affecting two consecutive generations. John XXIII's clinical tumour (cTN) was classified as cT4bN3a (IV stage). In two other cases, gastric carcinomas were classified as intestinal histotype and staged as pT1bN0 and pT2N2, respectively.

CONCLUSIONS

Pope John XXIII's family presents a strong aggregation for gastric cancer affecting almost seven members; it spreads through two consecutive generations. In absence of defined genetic causes and considering the increased risk of gastric cancer's development in these families, as well as the high mortality rates and advanced stages, we propose an intensive surveillance protocol for asymptomatic members.

摘要

背景

遗传性弥漫型胃癌与 E-钙黏蛋白种系突变有关,但家族性肠型胃癌的遗传决定因素尚未确定。遗传性弥漫型胃癌的指南已经明确制定;然而,对于家族性肠型胃癌的管理尚无明确的建议。

方法

在本研究中,我们描述了教皇约翰二十三世的家族系谱,其中包括胃癌以及其他六名家族成员。家族史按照国际胃癌连锁研究协会的标准进行分析,胃肿瘤的分类符合日本最新的指南。

结果

该家族系谱中的 109 名成员中有 7 人患有胃癌,影响了两代人。约翰二十三世的临床肿瘤(cTN)被归类为 cT4bN3a(IV 期)。在另外两例中,胃癌被归类为肠型,分期分别为 pT1bN0 和 pT2N2。

结论

教皇约翰二十三世的家族中,有近 7 名成员强烈聚集患有胃癌,且通过两代人传播。由于这些家族中胃癌发生的风险增加,以及高死亡率和晚期阶段,在没有明确遗传原因的情况下,我们建议对无症状成员进行强化监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb21/3591243/36a139899691/BMRI2013-385132.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb21/3591243/1e00b19160aa/BMRI2013-385132.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb21/3591243/d300ef436da0/BMRI2013-385132.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb21/3591243/f728045ef84b/BMRI2013-385132.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb21/3591243/36a139899691/BMRI2013-385132.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb21/3591243/1e00b19160aa/BMRI2013-385132.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb21/3591243/d300ef436da0/BMRI2013-385132.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb21/3591243/f728045ef84b/BMRI2013-385132.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb21/3591243/36a139899691/BMRI2013-385132.004.jpg

相似文献

1
History, pathogenesis, and management of familial gastric cancer: original study of John XXIII's family.家族性胃癌的历史、发病机制和治疗:约翰二十三世家族的原始研究。
Biomed Res Int. 2013;2013:385132. doi: 10.1155/2013/385132. Epub 2012 Dec 26.
2
Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.CDH1 种系突变患者中遗传性弥漫性胃癌检测标准和结果的准确性。
Gastroenterology. 2015 Oct;149(4):897-906.e19. doi: 10.1053/j.gastro.2015.06.003. Epub 2015 Jun 11.
3
Gastric cancer: new genetic developments.胃癌:新的遗传学进展
J Surg Oncol. 2005 Jun 1;90(3):114-33; discussion 133. doi: 10.1002/jso.20214.
4
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.遗传性弥漫性胃癌家族中的CDH1基因创始突变和复发性突变
JAMA. 2007 Jun 6;297(21):2360-72. doi: 10.1001/jama.297.21.2360. Epub 2007 Jun 3.
5
Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation.一名患有E-钙黏蛋白种系突变的家族性胃癌患者发生弥漫型胃癌和小叶型乳腺癌。
Am J Pathol. 1999 Aug;155(2):337-42. doi: 10.1016/S0002-9440(10)65129-2.
6
Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations.家族性胃癌:临床病理特征、错配修复蛋白表达表型及种系p53和E-钙黏蛋白突变
Carcinogenesis. 1999 Jun;20(6):1127-31. doi: 10.1093/carcin/20.6.1127.
7
Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.对胃癌家族进行E-钙黏蛋白筛查发现,仅在遗传性弥漫性胃癌家系中存在胚系突变。
Hum Mutat. 2002 May;19(5):510-7. doi: 10.1002/humu.10068.
8
E-cadherin germline mutations in familial gastric cancer.家族性胃癌中的E-钙黏蛋白种系突变
Nature. 1998 Mar 26;392(6674):402-5. doi: 10.1038/32918.
9
Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.E-钙黏蛋白的种系突变并不能解释遗传性前列腺癌、胃癌和乳腺癌之间的关联。
Int J Cancer. 2002 Apr 20;98(6):838-43. doi: 10.1002/ijc.10258.
10
Familial gastric cancer: overview and guidelines for management.家族性胃癌:概述与管理指南
J Med Genet. 1999 Dec;36(12):873-80.

引用本文的文献

1
Hereditary Gastrointestinal Tumor Syndromes: When Risk Comes with Your Genes.遗传性胃肠肿瘤综合征:当风险与基因相伴。
Curr Issues Mol Biol. 2024 Jun 26;46(7):6440-6471. doi: 10.3390/cimb46070385.
2
Endoscopic Surveillance in Patients with the Highest Risk of Gastric Cancer: Challenges and Solutions.胃癌高危患者的内镜监测:挑战与解决方案
Cancer Manag Res. 2022 Oct 10;14:2953-2969. doi: 10.2147/CMAR.S277898. eCollection 2022.
3
Hereditary Diffuse Gastric Cancer-Update Based on the Current Consort Recommendations.遗传性弥漫性胃癌——基于当前共识推荐的更新。

本文引用的文献

1
Association of the interval between endoscopies with gastric cancer stage at diagnosis in a region of high prevalence.高发地区内镜检查间隔与胃癌诊断时分期的关系。
Cancer. 2012 Oct 15;118(20):4953-60. doi: 10.1002/cncr.27495. Epub 2012 Jul 16.
2
Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance.家族性胃癌:诊断、治疗和定期监测指南。
Fam Cancer. 2012 Sep;11(3):363-9. doi: 10.1007/s10689-012-9521-y.
3
Effect of annual endoscopic screening on clinicopathologic characteristics and treatment modality of gastric cancer in a high-incidence region of Korea.
Curr Oncol. 2022 Mar 30;29(4):2454-2460. doi: 10.3390/curroncol29040199.
4
Helichrysetin inhibits gastric cancer growth by targeting c-Myc/PDHK1 axis-mediated energy metabolism reprogramming.海乳草素通过靶向 c-Myc/PDHK1 轴介导的能量代谢重编程抑制胃癌生长。
Acta Pharmacol Sin. 2022 Jun;43(6):1581-1593. doi: 10.1038/s41401-021-00750-0. Epub 2021 Aug 30.
5
Family History and Gastric Cancer Risk: A Pooled Investigation in the Stomach Cancer Pooling (STOP) Project Consortium.家族病史与胃癌风险:胃癌合并(STOP)项目联盟的汇总调查
Cancers (Basel). 2021 Jul 30;13(15):3844. doi: 10.3390/cancers13153844.
6
Clinical, Molecular and Genetic Characteristics of Early Onset Gastric Cancer: Analysis of a Large Multicenter Study.早期胃癌的临床、分子和遗传特征:一项大型多中心研究分析
Cancers (Basel). 2021 Jun 23;13(13):3132. doi: 10.3390/cancers13133132.
7
Galangin Inhibits Gastric Cancer Growth Through Enhancing STAT3 Mediated ROS Production.高良姜素通过增强STAT3介导的活性氧生成来抑制胃癌生长。
Front Pharmacol. 2021 Apr 26;12:646628. doi: 10.3389/fphar.2021.646628. eCollection 2021.
8
Association between Polyphenol Intake and Gastric Cancer Risk by Anatomic and Histologic Subtypes: MCC-Spain.多酚摄入与解剖学和组织学亚型胃癌风险的关联:MCC-Spain。
Nutrients. 2020 Oct 26;12(11):3281. doi: 10.3390/nu12113281.
9
Family history of gastric mucosal abnormality and the risk of gastric cancer: a population-based observational study.家族性胃黏膜异常史与胃癌风险:基于人群的观察性研究。
Int J Epidemiol. 2018 Apr 1;47(2):440-449. doi: 10.1093/ije/dyx238.
10
Targeted therapies for gastric cancer: failures and hopes from clinical trials.胃癌的靶向治疗:临床试验中的失败与希望
Oncotarget. 2017 Jan 26;8(34):57654-57669. doi: 10.18632/oncotarget.14825. eCollection 2017 Aug 22.
韩国高发地区年度内镜筛查对胃癌临床病理特征及治疗方式的影响。
Int J Cancer. 2012 Nov 15;131(10):2376-84. doi: 10.1002/ijc.27501. Epub 2012 Apr 16.
4
Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).胃黏膜癌前状态和病变的管理(MAPS):欧洲胃肠道内镜学会(ESGE)、欧洲幽门螺杆菌研究组(EHSG)、欧洲病理学会(ESP)和葡萄牙消化内镜学会(SPED)的指南。
Virchows Arch. 2012 Jan;460(1):19-46. doi: 10.1007/s00428-011-1177-8. Epub 2011 Dec 22.
5
Familial gastric cancer: update for practice management.家族性胃癌:实践管理更新。
Fam Cancer. 2011 Jun;10(2):391-6. doi: 10.1007/s10689-010-9410-1.
6
E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer.E-钙黏蛋白基因筛查与早发性胃癌的临床病理特征。
Eur J Cancer. 2011 Mar;47(4):631-9. doi: 10.1016/j.ejca.2010.10.011. Epub 2010 Nov 22.
7
Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.遗传性弥漫型胃癌:临床管理的更新共识指南和未来研究方向。
J Med Genet. 2010 Jul;47(7):436-44. doi: 10.1136/jmg.2009.074237.
8
Family history and the risk of gastric cancer.家族史与胃癌风险。
Br J Cancer. 2010 Jan 19;102(2):237-42. doi: 10.1038/sj.bjc.6605380. Epub 2009 Nov 3.
9
Familial gastric cancer and Li-Fraumeni syndrome.家族性胃癌与 Li-Fraumeni 综合征。
Eur J Cancer Care (Engl). 2010 May;19(3):377-81. doi: 10.1111/j.1365-2354.2008.01066.x. Epub 2009 Aug 7.
10
Family history of cancer and stomach cancer risk.癌症家族史与胃癌风险
Int J Cancer. 2008 Sep 15;123(6):1429-32. doi: 10.1002/ijc.23688.